Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men
Figure 2
Fasting acylation-stimulating protein (ASP) levels are shown for abdominally obese subjects (waist/hip ratio > 0.95, ) compared to nonobese subjects (waist/hip ratio < 0.95, ). Data is shown as average ± S.E.M. Groups were compared by independent sample t-test using Levene’s test for equality of variances.
